【Venue】JHVS Stage, Pacifico Yokohama
JHVS Exhibitor 90 sec. Elevator Pitch
Oct.9（Wed.） 13:45 ～ 14:45
Novel anti-TMEM180 mAb against Colorectal cancer and unique anti-insoluble fibrin Ab-drug conjugate etc.
Nobelpharma is Searching for Pharmaceutical and medical device with High Unmet Medical Needs.
M Bio Technology
Precision Preventative Medicine (ME-BYO) & Vaccine for Mycoplasma Infectious Diseases (MID)
Two nanomedicines solve Unmet Current Cancer Medical Care issues for cancer diagnosis and therapy.
LTT is a drug discovery venture that conducts basic research and clinical development with DR / DDS.
Applications of bio-molecular recognition for the novel Peptide-array and novel gene-control drugs, PIPA-peptides
Xcoo will share their acitivities aiming at continuous development in genomic medicine with AI.
Introducing our algorithm for predictive information derived from ANS and our data science business.
Cats with renal failure received MSC containing statin PLGA nanoparticles twice, resulting in recovery.
Generation of immuno-suppressive Treg cell therapy for inflammatory diseases and immune rejection
PRIME Technology improves immune cell infiltration and CAR-T/TCR-T cell survival in the solid tumor.
HTS and target identification by affinity based screening technology
"Curing the incurable" via biomarker and cell therapy development based on immune repertoire analysys
Develop nasal vaccine against infectious diseases is our company business focus.
Biomarker discovery assisted by metabolomics and exosome strongly.
RNA Switch™ technology can identify an active state of microRNA in the living cells, and search for an active microRNA specific to certain cell types.
Development of DNA/RNA editing tools to be applied in the medical field
The next-gen of cell production by fabrics lead to industrial evolution for Regenrative Medicine.
By applying our actuator technology, we have produced a variety of products like electrical pipettes and dispensers, tube pump systems.
Custom monoclonal antibody production services, rabbit mAb and DNA immunization
We will contribute to maintaining human health by personalized controls of intestinal environment.
University of Tsukuba
The pitch describes our unique acceleration program "Research Studio" for academia startups in the medical field.
Started with the mission of ‘’creating the world that enable researchers devoting themselves to their works’’.
Introduce the Starnford Biodesign Program in Japan to develop innovation leaders for medical device
Japan Science and
Technology Agency (JST)
SUCCESS is a program to support for JST related startup companies and provides capital and hands-on to them.
KORTUC makes radiation therapy more effective, benefiting millions of cancer patients world wide.
Our Cyfuse mission is to create three-dimensional tissue with Bio 3D printers and provide regenerative medicine product for patients.
TOKIWA-Bio is developing original gene therapy vectors and looking for partners to advance clinical trials.
【JST】Himuka AM Pharma
New Drug Deveiopment For Refractory Inflammatory Bowel Diseases
Introduction to Shonan iPark which is a rapidly expanding science park launched by Takeda Pharmaceutical in April, 2018.
Oct.10（Thu.） 13:00 ～ 14:00
Our nanoparticle technology can deliver drugs more efficiently and be applied for any indications.
Kyoto Drug Discovery & Development
KDDD is a venture to develop innovative seeds from Kyoto Univ and to expand the indication to systemic from eye.
Developing immune-stimulants against scattered solid tumors by BC-PIV with trimeric TNFLSFs
Mechanism of new compound of 2ccPA(2-carba cyclic phosphatidic acid) and current clinical trial
A future societal health system realized through
Oral examination to detect non-illness of the body just by taking a picture of the oral cavity
The solutions of clinical trial of sleep for Pharmaceutical company by using small medical EEG device.
Perinatal e-Health platform "Melody i" using coud-type mobile fetal monitor for safe delivery.
"Super stethoscope" supports the diagnosis of heart disease by AI technology.
We're conducting a clinical trial applying the serum-free culture tech. for Mesenchymal Stem Cells.
PuREC's goal is to establish safe and effective stem cell transplantation therapy.
We introduce our clinical-stage projects, HGF gene therapy product, Decoy Oligonucleotide and DNA Vaccine.
GenoTune technology is based on the secure and precise genome-editing technique that no needs chromosomal breakage.
High-precision profiling of autoantibodies in human serum with HuPEX® comprehensive protein array as a “human substitute”
KOTAI will introduce the proprietary Immuno-AI platform for drug target and biomarker discoveries.
Modulate intracellular Protein-Protein Interactions (PPI) with α-helix/β-turn peptide mimetic small molecules
We will help you from the micro long-term sustained release formulation feasibility test to GMP production of your compound.
PHARMA FOODS INTERNATIONAL
"ALAgene" Technology is the unique antibody generation platform based on avian immune system.
We seek technology alliances and collaborative developments that leverage our targeted CNS DDS
Only our product's name recognition among the researcher is second-class. We will introduce innovative product series.
Animal Stem Cell
Animal Stem Cell Inc. is a consulting, R&D company with our original cell culture technology.
Okinawa Protein Tomography
OIST startup: Protein structure analysis services using Cryo-Electron Microscope
Rena is a TMDU's venture that realizes RNA targeting therapy with DNA/RNA heteroduplex oligonucleotide HDO.
Company aims at drug discovery targeting G-protein coupled receptors (GPCRs).
University of Yamanashi,
Center for Advancing Clinical Research
Transplantation of human corneal endothelial precursors(HCEP) cells using nanocomposite gel sheet help solve corneal endothelial disease.
Digital Hollywood University
Graduate School Digital Health Lab
Activity report of graduate students, promoting social implementation in the medical, health, and nursing fields
Fast Track Initiative
Fast Track Initiative (FTI) is a healthcare-focused venture capital firm.
Center for Clinical Research and
Innovation (CCRI), Osaka City
CCRI's support schemes for innovation creation and its initiatives to produce innovations in cooperation with CMC
Japan Association for
the Advancement of Medical Equipment
Information about medical device information database "JAAME Seach".
Clinical development of novel cancer gene therapy, Ad-SGE-REIC, using a tumor suppressor gene, REIC
Oct.10（Thu.） 14:30 ～ 15:30
Seeking for a pharma partner to codevelop/commercialize KP-100IT in acute spinal cord injury and ALS
Injectable CMG (curcumin monoglucuronide) as the superior anti-tumor agent on intactable cancers.
Development of selective CYP1B1 inhibitors for next-generation preventive drugs of breast cancer
We are developing "TAKC-02" as a drug candidate for steroid-resistant severe asthma which targets neutrophilic inflammation.
Open Innovation Programs
Six JP Pharmas welcome innovative drug seeds & platform technologies leading to novel therapeutics.
Oita University Institute of
Small molecule compound library targeted to inhibit protein-protein interaction
Fabricate scaffold-free cell block without gel or any additives.
Bed sensor that can monitor vital data of sleeping person by "unnoticed sensing"
Tailor-made cardiac support net treat an exacerbation of severe heart failure by wrapping the heart.
「ME-BYO project」 (A system that can check, analyze and manage health from skin condition [reference: http://japanhpn.org/en/hnf21/]
The title of Cellusion presentation is "Regenerative medicine for corneal blindness by iPS cells".
Development of highly functional cells E-MNC and cell therapy drug with inovative DC method.
Gene Techno Science
R&D in cell therapy field using stem cells from human exfoliated deciduous teeth(SHED), and SHED bank business.
Our Fukabody platform develops VNAR single domain antibodies using Japanese local shark.
SOCIUM is developing the computational and experimental platform for drug discovery.
Single-cell resolution “next-generation microbiome analysis” technology / platform and it’s potential application toward the future will be presented.
A proprietary genome editing techniques using CRISPR/Cas3 with unprecedentedely high specificity and capability for large scale gene editing
Cell sorter using microfluidic chip. Drug evaluation, antibody-producing cell screening, CTC analysis
AI technology of MOLCURE for pharma company discovers novel drug molecules only from our platform.
Disposable manufacturing system, SINGLE-USE-SYSTEM for Tissue Engineering. Supporting industrialization with innovative production technology.
We are looking for collaborators interested in monoclonal antibody development from human B cells.
We generate unique DNA aptamers using proprietary technology. Exploring partnership with Pharma/Biotechs.
Division for Development of
A novel technology to both rapidly and effectively generate new scFvs optimal for immunotherapy.
Rotating culture device and cell growth recording device using octagonal bottle.
National Institutes of
Health and Nutrition
Researches for health promotion through big data analysis on microbiome, diet, and health status.
Beyond Next Ventures
"Pushing beyond the boundaries of tomorrow" with Beyond Next Ventures
【CoLaborator Kobe】Bayer Yakuhin
Introduction of "CoLaborator Kobe", Bayer's unique incubator lab for biotech startups in Japan.
Introduction to Epigeneron's core technologies which enable to develop first-in-class drugs and detection of gene mutations.
Introduction of Myoridge's protein-free cardiac differentiation technology.
MedRx is a pharmaceutical company devoting to creating and developing technologies and products that fulfill the unmet medical needs of patients.